Annual Interest Expense
$57.67 M
+$6.51 M+12.73%
31 December 2023
Summary:
Cytokinetics Incorporated annual interest expense is currently $57.67 million, with the most recent change of +$6.51 million (+12.73%) on 31 December 2023. During the last 3 years, it has risen by +$18.99 million (+49.11%). CYTK annual interest expense is now at all-time high.CYTK Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$22.30 M
-$2.00 M-8.23%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly interest expense is currently $22.30 million, with the most recent change of -$2.00 million (-8.23%) on 30 September 2024. Over the past year, it has increased by +$8.30 million (+59.32%). CYTK quarterly interest expense is now -8.23% below its all-time high of $24.30 million, reached on 30 June 2024.CYTK Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$80.98 M
+$8.30 M+11.42%
30 September 2024
Summary:
Cytokinetics Incorporated TTM interest expense is currently $80.98 million, with the most recent change of +$8.30 million (+11.42%) on 30 September 2024. Over the past year, it has increased by +$24.11 million (+42.39%). CYTK TTM interest expense is now at all-time high.CYTK TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.7% | +59.3% | +42.4% |
| 3 y3 years | +49.1% | +213.3% | +163.8% |
| 5 y5 years | +167.4% | +234.5% | +223.8% |
CYTK Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +96.6% | -8.2% | +213.3% | at high | +176.1% |
| 5 y | 5 years | at high | +167.4% | -8.2% | +234.5% | at high | +223.8% |
| alltime | all time | at high | -8.2% | >+9999.0% | at high | >+9999.0% |
Cytokinetics Incorporated Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.30 M(-8.2%) | $80.98 M(+11.4%) |
| June 2024 | - | $24.30 M(+40.3%) | $72.68 M(+17.7%) |
| Mar 2024 | - | $17.32 M(+1.5%) | $61.75 M(+7.1%) |
| Dec 2023 | $57.67 M(+12.7%) | $17.06 M(+21.9%) | $57.67 M(+1.4%) |
| Sept 2023 | - | $14.00 M(+4.7%) | $56.87 M(-3.0%) |
| June 2023 | - | $13.37 M(+1.0%) | $58.64 M(+6.5%) |
| Mar 2023 | - | $13.24 M(-18.6%) | $55.09 M(+7.7%) |
| Dec 2022 | $51.16 M(+74.4%) | $16.27 M(+3.2%) | $51.16 M(+17.9%) |
| Sept 2022 | - | $15.77 M(+60.7%) | $43.38 M(+24.9%) |
| June 2022 | - | $9.81 M(+5.4%) | $34.73 M(+9.0%) |
| Mar 2022 | - | $9.31 M(+9.7%) | $31.86 M(+8.6%) |
| Dec 2021 | $29.33 M(-24.2%) | $8.49 M(+19.3%) | $29.33 M(-4.4%) |
| Sept 2021 | - | $7.12 M(+2.5%) | $30.70 M(-7.0%) |
| June 2021 | - | $6.94 M(+2.4%) | $33.02 M(-8.0%) |
| Mar 2021 | - | $6.78 M(-31.2%) | $35.88 M(-7.2%) |
| Dec 2020 | $38.68 M(+41.4%) | $9.85 M(+4.4%) | $38.68 M(+4.3%) |
| Sept 2020 | - | $9.44 M(-3.7%) | $37.09 M(+8.1%) |
| June 2020 | - | $9.80 M(+2.3%) | $34.32 M(+10.9%) |
| Mar 2020 | - | $9.58 M(+15.9%) | $30.95 M(+13.1%) |
| Dec 2019 | $27.36 M(+26.9%) | $8.26 M(+24.0%) | $27.36 M(+9.4%) |
| Sept 2019 | - | $6.67 M(+3.5%) | $25.01 M(+5.2%) |
| June 2019 | - | $6.44 M(+7.5%) | $23.77 M(+5.3%) |
| Mar 2019 | - | $5.99 M(+1.3%) | $22.56 M(+4.6%) |
| Dec 2018 | $21.56 M(+26.9%) | $5.91 M(+8.9%) | $21.56 M(+5.8%) |
| Sept 2018 | - | $5.43 M(+3.6%) | $20.39 M(+3.6%) |
| June 2018 | - | $5.24 M(+4.9%) | $19.67 M(+3.9%) |
| Mar 2018 | - | $4.99 M(+5.5%) | $18.93 M(+11.4%) |
| Dec 2017 | $17.00 M(+529.9%) | $4.73 M(+0.4%) | $17.00 M(+31.0%) |
| Sept 2017 | - | $4.71 M(+4.7%) | $12.98 M(+44.5%) |
| June 2017 | - | $4.50 M(+47.4%) | $8.98 M(+73.1%) |
| Mar 2017 | - | $3.05 M(+328.1%) | $5.19 M(+92.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $2.70 M(+906.7%) | $713.00 K(-0.1%) | $2.70 M(+19.8%) |
| Sept 2016 | - | $714.00 K(+1.0%) | $2.25 M(+46.4%) |
| June 2016 | - | $707.00 K(+25.6%) | $1.54 M(+85.1%) |
| Mar 2016 | - | $563.00 K(+110.1%) | $831.00 K(+210.1%) |
| Dec 2015 | $268.00 K(>+9900.0%) | $268.00 K(>+9900.0%) | $268.00 K(+211.6%) |
| Sept 2015 | - | $0.00(-100.0%) | $86.00 K(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $86.00 K(-418.5%) | $0.00(-100.0%) |
| Sept 2014 | - | -$27.00 K(-18.2%) | -$8000.00(+100.0%) |
| June 2014 | - | -$33.00 K(+26.9%) | -$4000.00(-300.0%) |
| Mar 2014 | - | -$26.00 K(-133.3%) | $2000.00(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $78.00 K(-439.1%) | $0.00(-100.0%) |
| Sept 2013 | - | -$23.00 K(-14.8%) | -$78.00 K(+44.4%) |
| June 2013 | - | -$27.00 K(-3.6%) | -$54.00 K(+100.0%) |
| Mar 2013 | - | -$28.00 K(<-9900.0%) | -$27.00 K(-775.0%) |
| Dec 2012 | $2000.00(-94.9%) | $0.00(-100.0%) | $4000.00(-55.6%) |
| Sept 2012 | - | $1000.00(-66.7%) | $9000.00(-69.0%) |
| Mar 2012 | - | $3000.00(-40.0%) | $29.00 K(-29.3%) |
| Dec 2011 | $39.00 K(-76.1%) | $5000.00(-28.6%) | $41.00 K(-26.8%) |
| Sept 2011 | - | $7000.00(-50.0%) | $56.00 K(-9.7%) |
| June 2011 | - | $14.00 K(-6.7%) | $62.00 K(-43.1%) |
| Mar 2011 | - | $15.00 K(-25.0%) | $109.00 K(-33.1%) |
| Dec 2010 | $163.00 K(-60.1%) | $20.00 K(+53.8%) | $163.00 K(-30.6%) |
| Sept 2010 | - | $13.00 K(-78.7%) | $235.00 K(-28.4%) |
| June 2010 | - | $61.00 K(-11.6%) | $328.00 K(-13.2%) |
| Mar 2010 | - | $69.00 K(-25.0%) | $378.00 K(-7.6%) |
| Dec 2009 | $409.00 K(-16.7%) | $92.00 K(-13.2%) | $409.00 K(+29.0%) |
| Sept 2009 | - | $106.00 K(-4.5%) | $317.00 K(+50.2%) |
| June 2009 | - | $111.00 K(+11.0%) | $211.00 K(-10.2%) |
| Mar 2009 | - | $100.00 K(-25.9%) | $235.00 K(+74.1%) |
| Dec 2008 | $491.00 K | - | - |
| June 2008 | - | $135.00 K | $135.00 K |
FAQ
- What is Cytokinetics Incorporated annual interest expense?
- What is the all time high annual interest expense for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual interest expense year-on-year change?
- What is Cytokinetics Incorporated quarterly interest expense?
- What is the all time high quarterly interest expense for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly interest expense year-on-year change?
- What is Cytokinetics Incorporated TTM interest expense?
- What is the all time high TTM interest expense for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM interest expense year-on-year change?
What is Cytokinetics Incorporated annual interest expense?
The current annual interest expense of CYTK is $57.67 M
What is the all time high annual interest expense for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual interest expense is $57.67 M
What is Cytokinetics Incorporated annual interest expense year-on-year change?
Over the past year, CYTK annual interest expense has changed by +$6.51 M (+12.73%)
What is Cytokinetics Incorporated quarterly interest expense?
The current quarterly interest expense of CYTK is $22.30 M
What is the all time high quarterly interest expense for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly interest expense is $24.30 M
What is Cytokinetics Incorporated quarterly interest expense year-on-year change?
Over the past year, CYTK quarterly interest expense has changed by +$8.30 M (+59.32%)
What is Cytokinetics Incorporated TTM interest expense?
The current TTM interest expense of CYTK is $80.98 M
What is the all time high TTM interest expense for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM interest expense is $80.98 M
What is Cytokinetics Incorporated TTM interest expense year-on-year change?
Over the past year, CYTK TTM interest expense has changed by +$24.11 M (+42.39%)